Concurrent Investment Advisors
PROF icon

Concurrent Investment Advisors’s Profound Medical PROF Stock Holding History

Concurrent Investment Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$126K Hold
21,657
– – ﹤0.01% 2252
2026
Q2 		$144K Buy
+21,657
New +$146K ﹤0.01% 1996

Other funds holding PROF

RMC
Ring Mountain Capital Tiburon, California $245M AUM 48.62% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
PM
Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return

Concurrent Investment Advisors's PROF Position: Q3 2026 in Review

Concurrent Investment Advisors held its Profound Medical (PROF) position steady in Q3 2026 at 21,657 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #2252.

Concurrent Investment Advisors first reported a position in PROF in Q2 2026 and has held it in 2 quarters since. The position peaked at $144K in Q2 2026. 4 funds tracked by Wall St. Rank hold PROF as of Q3 2026.

  • Concurrent Investment Advisors held 21,657 shares of Profound Medical worth $126K as of Q3 2026.
  • Concurrent Investment Advisors left its Profound Medical share count unchanged in Q3 2026.
  • Profound Medical made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q3 2026, its #2252 holding.
  • Concurrent Investment Advisors first reported a position in Profound Medical in Q2 2026 and has held it in 2 quarters since.
  • Concurrent Investment Advisors's Profound Medical position peaked at $144K in Q2 2026.
  • 4 funds tracked by Wall St. Rank held Profound Medical as of Q3 2026.

Based on Concurrent Investment Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.